Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun;55(12):1588-1589.
doi: 10.1111/apt.16956.

Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition

Jeffrey A Berinstein  1   2   3 , A Mark Fendrick  2   3   4
Affiliations
Free article
Editorial

Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition

Jeffrey A Berinstein et al. Aliment Pharmacol Ther. 2022 Jun.
Free article
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

REFERENCES

    1. Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(10):908-17. https://doi.org/10.1016/S2468-1253(20)30217-X
    1. Goodoory VC, Black CJ, Ford AC. Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom. Aliment Pharmacol Ther. 2022; DOI: 10.1111/apt.16939.
    1. Nyrop KA, Palsson OS, Levy RL, et al. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol Ther. 2007;26(2):237-48. https://doi.org/10.1111/j.1365-2036.2007.03370.x
    1. Akehurst RL, Brazier JE, Mathers N, O’Keefe C, Kaltenthaler E, Morgan A, et al. Health-related quality of life and cost impact of irritable bowel syndrome in a UKprimary care setting. PharmacoEconomics. 2002;20(7):455-62. https://doi.org/10.2165/00019053-200,220,070-00003
    1. Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther. 2014;40(9):1023-34.

LinkOut - more resources